PATIENTS

Building Obesity Care That Lasts

Starting obesity treatment is only the beginning. Patients need support to navigate access, treatment demands, and everyday barriers over time, and that responsibility is shared across the healthcare system.

By: Susan Sweeney, Executive Vice President, Obesity and Related Conditions, Amgen

This article was originally published on HTLH.com and is reposted with permission.

We're living through a period of remarkable progress in obesity science, alongside growing recognition of obesity as a complex, chronic, relapsing disease. But scientific advances alone won't solve one of the field's biggest challenges: helping people access effective care and sustain it over time.

For many people living with obesity, the decision to seek treatment comes after years of navigating stigma, misinformation, and barriers to care. Starting treatment is an important milestone, but it's only the beginning of a much longer journey.

Across the healthcare ecosystem, we all share a responsibility to meet people where they are in this journey, and to ask ourselves honestly: how can we make it possible for people to fully realize the benefit of obesity treatment long term?

Making the first step possible

Starting obesity treatment requires more than a prescription. It requires the entire healthcare system—clinicians, payers, employers, and communities—to recognize obesity as a complex, chronic, relapsing disease, and understand the barriers people face in seeking care.

I've heard from people who spent years being told to simply “try diet and exercise,” often leaving them feeling dismissed or discouraged. Those experiences, compounded by misinformation, stigma, and challenges accessing treatment, can make taking the first step even harder.

The burden of obesity often shows up in moments others may rarely consider—from finding clothes that fit to navigating travel or important milestones. These experiences accumulate over years, shaping how people feel about themselves and whether they seek care. By the time many people arrive at treatment, they are already carrying years of frustration and fatigue.

Understanding the persistence gap

Getting started is only part of the challenge. Obesity requires long-term management, yet people struggle to remain on treatment. Approximately 55% of patients with obesity discontinue GLP-1 therapy within one year, and many of those patients go on to cycle on and off treatment after the initial discontinuation, underscoring the gap between scientific progress and what patients experience in everyday care.

The reasons are complex, and the challenges extend beyond treatment itself. For many, scheduling doses, managing supplies, and navigating the cognitive burden can all influence whether patients are able to continue treatment. For those who have already spent years feeling dismissed by the healthcare system, rushed appointments, generic advice, and a lack of support between visits can make the path to sustained weight loss even harder.

Defining success beyond the scale

So what does it look like to build care that lasts? It starts with a connected healthcare ecosystem. No single medicine, clinician, technology, or organization can address these challenges alone.

Clinicians need to be equipped to have meaningful conversations with patients, payers, and employers, and healthcare systems must consider not only whether treatment works, but whether people can realistically access and sustain it.

Innovation must extend beyond science itself. From conversation around care, side effects, and dosing schedules, to insurance navigation and ongoing support, we need to consider the full patient experience. And because obesity is associated with cardiovascular disease, type 2 diabetes, obstructive sleep apnea, and more, our ambition must extend beyond weight loss to improving long-term health outcomes.

The next frontier of obesity care will not be defined by how patients start treatment but by how they are able to stay engaged long enough to realize its full potential. When we design care that helps people throughout their journey, we move beyond treating obesity, and instead, move toward helping people realize improvements in related health outcomes over the long term.

Share This Story